Opko Health, Inc.
OPK
$1.20
$0.010.42%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -14.90% | -9.75% | -7.31% | -13.78% | -17.41% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -14.90% | -9.75% | -7.31% | -13.78% | -17.41% |
| Cost of Revenue | -12.48% | -14.33% | -7.72% | -5.36% | -5.53% |
| Gross Profit | -27.71% | 24.31% | -4.77% | -42.34% | -50.42% |
| SG&A Expenses | -24.86% | -23.14% | -0.49% | -1.07% | 0.82% |
| Depreciation & Amortization | -5.74% | -5.49% | -5.65% | -5.74% | -3.95% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -15.72% | -16.28% | -5.46% | -4.13% | -3.53% |
| Operating Income | 17.87% | 31.30% | 0.51% | -34.65% | -72.32% |
| Income Before Tax | -2,225.33% | -35.34% | 37.67% | 99.77% | 94.37% |
| Income Tax Expenses | -136.68% | 31.59% | 1,664.42% | 1,972.44% | 865.58% |
| Earnings from Continuing Operations | -324.02% | -34.89% | 27.13% | 84.55% | 71.82% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -324.02% | -34.89% | 27.13% | 84.55% | 71.82% |
| EBIT | 17.87% | 31.30% | 0.51% | -34.65% | -72.32% |
| EBITDA | 24.18% | 43.01% | -3.74% | -82.42% | -230.13% |
| EPS Basic | -307.69% | -31.26% | 29.83% | 82.79% | 70.51% |
| Normalized Basic EPS | -412.19% | 58.94% | 23.23% | 76.40% | 62.09% |
| EPS Diluted | -272.78% | -28.20% | 28.30% | 80.87% | 68.04% |
| Normalized Diluted EPS | -360.65% | 36.75% | 20.40% | 73.40% | 57.88% |
| Average Basic Shares Outstanding | 8.17% | 2.22% | -2.62% | -7.48% | -7.68% |
| Average Diluted Shares Outstanding | -10.41% | 1.19% | 17.29% | 12.07% | 11.58% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |